Skip to main content
Erschienen in:

27.01.2022 | Magnetic Resonance

Proximal nerve MR neurography with diffusion tensor imaging in differentiating subtypes of Charcot-Marie-Tooth disease

verfasst von: Xingwen Sun, Xiaoxuan Liu, Qiang Zhao, Mengze Zhang, Lihua Zhang, Huishu Yuan

Erschienen in: European Radiology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the feasibility of proximal nerve MR neurography with diffusion tensor imaging (DTI) for differentiating Charcot-Marie-Tooth (CMT) 1A, CMT2, and healthy controls.

Methods

The diameters, fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) of L4-L5 nerve roots, femoral nerve (FN), and sciatic nerve (SN) were compared. Receiver operating characteristic (ROC) curve analyses were conducted to evaluate the diagnostic performance. DeLong’s tests were applied to compare multiple ROC curves. Intraclass correlation coefficients were calculated for interobserver agreement assessment.

Results

The diameters of the L4 nerve root, L5 nerve root, and SN of CMT1A patients were significantly larger than those of CMT2 patients and healthy controls. The FA values of all measured proximal nerves were significantly higher in controls (0.46 ± 0.09, 0.46 ± 0.08, 0.45 ± 0.07, and 0.48 ± 0.08) than in CMT1A patients (0.30 ± 0.09, 0.29 ± 0.06, 0.35 ± 0.08, and 0.29 ± 0.09). The FA values of the L5 nerve root, FN, and SN were significantly higher in controls (0.46 ± 0.08, 0.45 ± 0.07, and 0.48 ± 0.08) than in CMT2 patients (0.36 ± 0.06, 0.34 ± 0.07, and 0.34 ± 0.10). The MD and RD values of the L5 nerve root in CMT1A patients (1.59 ± 0.21 and 1.37 ± 0.21) were higher than those in CMT2 patients (1.31 ± 0.17 and 1.05 ± 0.14). The AUCs of the above parameters ranged from 0.780 to 1.000. For the measurements of nerve diameters, the ICC ranged from 0.91 to 0.97. For the measurements of DTI metrics, the ICC ranged from 0.87 to 0.97.

Conclusions

MR neurography with DTI is able to differentiate CMT1A patients, CMT2 patients, and healthy controls.

Key Points

MR neurography with diffusion tensor imaging of the L4-5 nerve roots, proximal femoral nerve, and proximal sciatic nerve is able to discriminate CMT1A, CMT2, and healthy controls.
This method provides an alternative for the diagnosis and discrimination of CMT1A and CMT2, which is crucial for clinical management.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Martyn CN, Hughes RA (1997) Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 624:310–318CrossRef Martyn CN, Hughes RA (1997) Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 624:310–318CrossRef
2.
Zurück zum Zitat Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 87:654–667CrossRef Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 87:654–667CrossRef
3.
Zurück zum Zitat Barisic N, Claeys KG, Sirotkovic-Skerlev M et al (2008) Charcot-Marie-Tooth disease: a clinico-genetic confrontation. Ann Hum Genet 72(Pt 3):416–41CrossRef Barisic N, Claeys KG, Sirotkovic-Skerlev M et al (2008) Charcot-Marie-Tooth disease: a clinico-genetic confrontation. Ann Hum Genet 72(Pt 3):416–41CrossRef
4.
Zurück zum Zitat Szigeti K, Lupski JR (2009) Charcot-Marie-Tooth disease. Eur J Hum Genet 176:703–710CrossRef Szigeti K, Lupski JR (2009) Charcot-Marie-Tooth disease. Eur J Hum Genet 176:703–710CrossRef
5.
Zurück zum Zitat Lupski JR, de Oca-Luna RM, Slaugenhaupt S et al (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 662:219–232CrossRef Lupski JR, de Oca-Luna RM, Slaugenhaupt S et al (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 662:219–232CrossRef
6.
Zurück zum Zitat Robertson AM, Perea J, McGuigan A et al (2002) Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J Anat 2004:377–390CrossRef Robertson AM, Perea J, McGuigan A et al (2002) Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J Anat 2004:377–390CrossRef
7.
Zurück zum Zitat Fridman V, Bundy B, Reilly MM et al (2015) CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry 868:873–878CrossRef Fridman V, Bundy B, Reilly MM et al (2015) CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry 868:873–878CrossRef
8.
Zurück zum Zitat Rossor AM, Polke JM, Houlden H, Reilly MM (2013) Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol 910:562–571CrossRef Rossor AM, Polke JM, Houlden H, Reilly MM (2013) Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol 910:562–571CrossRef
9.
Zurück zum Zitat Dortch RD, Dethrage LM, Gore JC, Smith SA, Li J (2014) Proximal nerve magnetization transfer MRI relates to disability in Charcot-Marie-Tooth diseases. Neurology 8317:1545–1553CrossRef Dortch RD, Dethrage LM, Gore JC, Smith SA, Li J (2014) Proximal nerve magnetization transfer MRI relates to disability in Charcot-Marie-Tooth diseases. Neurology 8317:1545–1553CrossRef
10.
Zurück zum Zitat Padua L, Aprile I, Caliandro P, Pazzaglia C, Commodari I, Tonali P (2006) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 664:614–5; author reply 614–5 Padua L, Aprile I, Caliandro P, Pazzaglia C, Commodari I, Tonali P (2006) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 664:614–5; author reply 614–5
11.
Zurück zum Zitat Lawson VH, Arnold WD (2014) Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment. Neuropsychiatr Dis Treat 10:567–576PubMedPubMedCentral Lawson VH, Arnold WD (2014) Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment. Neuropsychiatr Dis Treat 10:567–576PubMedPubMedCentral
12.
Zurück zum Zitat Thawait SK, Chaudhry V, Thawait GK et al (2011) High-resolution MR neurography of diffuse peripheral nerve lesions. AJNR Am J Neuroradiol 328:1365–1372CrossRef Thawait SK, Chaudhry V, Thawait GK et al (2011) High-resolution MR neurography of diffuse peripheral nerve lesions. AJNR Am J Neuroradiol 328:1365–1372CrossRef
13.
Zurück zum Zitat Chen YY, Zhang X, Lin XF et al (2017) DTI metrics can be used as biomarkers to determine the therapeutic effect of stem cells in acute peripheral nerve injury. J Magn Reson Imaging 453:855–862CrossRef Chen YY, Zhang X, Lin XF et al (2017) DTI metrics can be used as biomarkers to determine the therapeutic effect of stem cells in acute peripheral nerve injury. J Magn Reson Imaging 453:855–862CrossRef
14.
Zurück zum Zitat Kronlage M, Schwehr V, Schwarz D et al (2018) Peripheral nerve diffusion tensor imaging (DTI): normal values and demographic determinants in a cohort of 60 healthy individuals. Eur Radiol 285:1801–1808CrossRef Kronlage M, Schwehr V, Schwarz D et al (2018) Peripheral nerve diffusion tensor imaging (DTI): normal values and demographic determinants in a cohort of 60 healthy individuals. Eur Radiol 285:1801–1808CrossRef
15.
Zurück zum Zitat Vaeggemose M, Vaeth S, Pham M et al (2017) Magnetic resonance neurography and diffusion tensor imaging of the peripheral nerves in patients with Charcot-Marie-Tooth type 1A. Muscle Nerve 566:E78–E84CrossRef Vaeggemose M, Vaeth S, Pham M et al (2017) Magnetic resonance neurography and diffusion tensor imaging of the peripheral nerves in patients with Charcot-Marie-Tooth type 1A. Muscle Nerve 566:E78–E84CrossRef
16.
Zurück zum Zitat Kim HS, Yoon YC, Choi BO, Jin W, Cha JG, Kim JH (2019) Diffusion tensor imaging of the sciatic nerve in Charcot-Marie-Tooth disease type I patients: a prospective case-control study. Eur Radiol 296:3241–3252CrossRef Kim HS, Yoon YC, Choi BO, Jin W, Cha JG, Kim JH (2019) Diffusion tensor imaging of the sciatic nerve in Charcot-Marie-Tooth disease type I patients: a prospective case-control study. Eur Radiol 296:3241–3252CrossRef
17.
Zurück zum Zitat Choi SK, Bowers RP, Buckthal PE (1990) MR imaging in hypertrophic neuropathy: a case of hereditary motor and sensory neuropathy, type I (Charcot-Marie-Tooth). Clin Imaging 143:204–207CrossRef Choi SK, Bowers RP, Buckthal PE (1990) MR imaging in hypertrophic neuropathy: a case of hereditary motor and sensory neuropathy, type I (Charcot-Marie-Tooth). Clin Imaging 143:204–207CrossRef
18.
Zurück zum Zitat Chung KW, Suh BC, Shy ME et al (2008) Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A. Neuromuscul Disord 188:610–618CrossRef Chung KW, Suh BC, Shy ME et al (2008) Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A. Neuromuscul Disord 188:610–618CrossRef
19.
Zurück zum Zitat Ellegala DB, Monteith SJ, Haynor D, Bird TD, Goodkin R, Kliot M (2005) Characterization of genetically defined types of Charcot-Marie-Tooth neuropathies by using magnetic resonance neurography. J Neurosurg 1022:242–245CrossRef Ellegala DB, Monteith SJ, Haynor D, Bird TD, Goodkin R, Kliot M (2005) Characterization of genetically defined types of Charcot-Marie-Tooth neuropathies by using magnetic resonance neurography. J Neurosurg 1022:242–245CrossRef
20.
Zurück zum Zitat Chhabra A, Carrino JA, Farahani SJ et al (2016) Whole-body MR neurography: prospective feasibility study in polyneuropathy and Charcot-Marie-Tooth disease. J Magn Reson Imaging 446:1513–1521CrossRef Chhabra A, Carrino JA, Farahani SJ et al (2016) Whole-body MR neurography: prospective feasibility study in polyneuropathy and Charcot-Marie-Tooth disease. J Magn Reson Imaging 446:1513–1521CrossRef
21.
Zurück zum Zitat Behse F, Buchthal F (1977) Peroneal muscular atrophy (PMA) and related disorders. II. Histological findings in sural nerves. Brain 100(Pt 1):67–85CrossRef Behse F, Buchthal F (1977) Peroneal muscular atrophy (PMA) and related disorders. II. Histological findings in sural nerves. Brain 100(Pt 1):67–85CrossRef
22.
Zurück zum Zitat Martinoli C, Schenone A, Bianchi S et al (2002) Sonography of the median nerve in Charcot-Marie-Tooth disease. AJR Am J Roentgenol 1786:1553–1556CrossRef Martinoli C, Schenone A, Bianchi S et al (2002) Sonography of the median nerve in Charcot-Marie-Tooth disease. AJR Am J Roentgenol 1786:1553–1556CrossRef
23.
Zurück zum Zitat Bienfait HM, Baas F, Koelman JH et al (2007) Phenotype of Charcot-Marie-Tooth disease type 2. Neurology 6820:1658–1667CrossRef Bienfait HM, Baas F, Koelman JH et al (2007) Phenotype of Charcot-Marie-Tooth disease type 2. Neurology 6820:1658–1667CrossRef
24.
Zurück zum Zitat Kronlage M, Pitarokoili K, Schwarz D et al (2017) Diffusion tensor imaging in chronic inflammatory demyelinating polyneuropathy: diagnostic accuracy and correlation with electrophysiology. Invest Radiol 5211:701–707CrossRef Kronlage M, Pitarokoili K, Schwarz D et al (2017) Diffusion tensor imaging in chronic inflammatory demyelinating polyneuropathy: diagnostic accuracy and correlation with electrophysiology. Invest Radiol 5211:701–707CrossRef
25.
Zurück zum Zitat Cheah PL, Krisnan T, Wong JHD et al (2021) Microstructural integrity of peripheral nerves in Charcot-Marie-Tooth disease: an MRI evaluation study. J Magn Reson Imaging 532:437–444CrossRef Cheah PL, Krisnan T, Wong JHD et al (2021) Microstructural integrity of peripheral nerves in Charcot-Marie-Tooth disease: an MRI evaluation study. J Magn Reson Imaging 532:437–444CrossRef
Metadaten
Titel
Proximal nerve MR neurography with diffusion tensor imaging in differentiating subtypes of Charcot-Marie-Tooth disease
verfasst von
Xingwen Sun
Xiaoxuan Liu
Qiang Zhao
Mengze Zhang
Lihua Zhang
Huishu Yuan
Publikationsdatum
27.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 6/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-021-08506-4

Neu im Fachgebiet Radiologie

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

PMBCL mit CMR: Radiatio kann ohne Risiko weggelassen werden

Patienten mit primär mediastinalem B-Zell-Lymphom (PMBCL), die nach der Induktionstherapie eine komplette metabolische Remission (CMR) erreichen und keine konsolidierende Bestrahlung erhalten, müssen offenbar keine Überlebensnachteile fürchten.

Hypoxisch-ischämische Enzephalopathie: Indikatoren für eine ungünstige Prognose

Eine US-amerikanische Studie widmete sich der Identifizierung prognostischer Parameter bei Neugeborenen mit mittelschwerer oder schwerer hypoxisch-ischämischer Enzephalopathie (HIE), die mittels induzierter Hypoxie behandelt wurden. Besonders im 24-Stunden-EEG und der MRT konnten relevante Hinweise gefunden werden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.